Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
ABUS
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -14.7%
ABUS
Arbutus Biopharma Corporation Common Stock
☁️ News word cloud
Top words across the last 50 articles for this ticker.
arbutus
2023
biopharma
clinical
2024
stage
virology
today
warminster
globe
newswire
nasdaq
biopharmaceutical
leveraging
extensive
expertise
develop
announced
hepatitis
conference